Market Value648,511,000
Total Holdings70
File Date2015-02-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NLTX / Neoleukin Therapeutics, Inc.
TSRO / TESARO, Inc.
NVAX / Novavax, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
CLVS / Clovis Oncology Inc
GEVA / Synageva Biopharma Corp
PBYI / Puma Biotechnology, Inc.
REPH / Societal CDMO Inc
NKTR / Nektar Therapeutics
SGMO / Sangamo Therapeutics, Inc.
NERV / Minerva Neurosciences, Inc.
KITE / Kite Pharma, Inc.
DRNA / Dicerna Pharmaceuticals Inc
NVRO / Nevro Corp.
KERX / Keryx Biopharmaceuticals, Inc.
RGLS / Regulus Therapeutics Inc.
ARAV / Aravive, Inc.
AGTC / Applied Genetic Technologies Corp
GNVC / GenVec, Inc.
NSTG / NanoString Technologies, Inc.
DERM / Journey Medical Corporation
JAZZ / Jazz Pharmaceuticals plc
CRIS / Curis, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
IMDZ / Immune Design Corp.
AGRX / Agile Therapeutics, Inc.
ADXS / Ayala Pharmaceuticals, Inc.
ZSPH / ZS Pharma, Inc.
ARROWHEAD RESH CORP / (042797209)
FWP / Forward Pharma A/S - ADR
AGIO / Agios Pharmaceuticals, Inc.
GALT / Galectin Therapeutics Inc.
ASPX / Auspex Pharmaceuticals, Inc.
BMYMP / Bristol-Myers Squibb Company - Preferred Security
LIPOCINE INC NEW / (05360X104)
EPRSQ / Epirus Biopharmaceuticals Inc
RMTI / Rockwell Medical, Inc.
RCPT / Receptos, Inc.
KPTI / Karyopharm Therapeutics Inc.
17K / Self Storage Group ASA
ALNY / Alnylam Pharmaceuticals, Inc.
QTNT / Quotient Ltd
BMY / Bristol-Myers Squibb Company
ACRX / Talphera, Inc.
VCYT / Veracyte, Inc.
DYAX / Dyax Corp.
TPST / Tempest Therapeutics, Inc.
CELG / Celgene Corp.
DARE / Daré Bioscience, Inc.
0PP / Portola Pharmaceuticals Inc
CBPO / China Biologic Products Holdings Inc
AGEN / Agenus Inc.
ARDX / Ardelyx, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
CMRX / Chimerix, Inc.
APTO / Aptose Biosciences Inc.
SRNE / Sorrento Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
15117F112 / Cellectar Biosciences, Inc. Series A Warrants
CLTX / Celsus Therapeutics
CLRB / Cellectar Biosciences, Inc.
ADVM / Adverum Biotechnologies, Inc.
AKBA / Akebia Therapeutics, Inc.
/ Array BioPharma, Inc.
GLYC / GlycoMimetics, Inc.
CHRS / Coherus Oncology, Inc.
SCYX / SCYNEXIS, Inc.
XLRN / Acceleron Pharma Inc
HRTX / Heron Therapeutics, Inc.
DXCM / DexCom, Inc.
PTCT / PTC Therapeutics, Inc.
EGRX / Eagle Pharmaceuticals, Inc.
ALKS / Alkermes plc
NBIX / Neurocrine Biosciences, Inc.
OMER / Omeros Corporation